TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8627643

Group type: COMPARATOR
Intervention: Bolus 5-FU at 500 mg/m2 for 5 days followed in 2 weeks by weekly bolus 5-FU at 600 mg/m2 (Treatment A)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: 5-FU at 300 mg/m2 per day by continuous infusion (Treatment C)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: 5-FU at 300 mg/m2 per day by continuous infusion plus weekly cisplatin at 20 mg/m2 (Treatment D)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Bolus 5-FU at 500 mg/m2 for 5 days followed in 2 weeks by weekly bolus 5-FU at 600 mg/m2 plus weekly cisplatin at 20 mg/m2 (Treatment B)
Number of subjects: 497
Study: 1471698

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6362905

Group type: EXPERIMENTAL
Intervention: 0.3 mg/day clonidine for 3 days
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 0.4 mg iv naloxone
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo treatment with naloxone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Clonidine treatment with naloxone
Number of subjects: 29
Study: 29590362

Group type: EXPERIMENTAL
Intervention: Frail individuals
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: Very frail individuals
Number of subjects: 1280

Group type: EXPERIMENTAL
Intervention: Robust individuals
Number of subjects: 1280
Study: 26852904

Group type: COMPARATOR
Intervention: GLPG0974 (single doses up to 250 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLPG0974 (multiple daily doses up to 400 mg for 14 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLPG0974
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24398645

Group type: EXPERIMENTAL
Intervention: Unrestricted consumption of fruits and vegetables
Number of subjects: 19
Study: 23523453

Group type: EXPERIMENTAL
Intervention: Endeavor zotarolimus-eluting stent (E-ZES)
Number of subjects: 1440

Group type: COMPARATOR
Intervention: Taxus paclitaxel-eluting stent (PES)
Number of subjects: 1440
Study: 20414532

Group type: EXPERIMENTAL
Intervention: 2 g of salt/day for 7 days (Phase 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 6 g of salt/day (subgroup 1, Phase 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 2 g of salt/day (subgroup II, Phase 2)
Number of subjects: 50
Study: 19088952

Group type: EXPERIMENTAL
Intervention: Topical metronidazole gel
Number of subjects: 39

Group type: COMPARATOR
Intervention: Scaling and root planing
Number of subjects: 39
Study: 16631658

Group type: EXPERIMENTAL
Intervention: High CO2 insufflation pressure (15 mm Hg)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Low CO2 insufflation pressure (12 mm Hg)
Number of subjects: 498
Study: 14617582

Group type: EXPERIMENTAL
Intervention: Edrophonium (0.5 mg x kg(‐1))
Number of subjects: 104

Group type: COMPARATOR
Intervention: Spontaneous recovery
Number of subjects: 104
Study: 10745385

Group type: EXPERIMENTAL
Intervention: Albendazole 600 mg every six months
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Placebo (calcium powder)
Number of subjects: 1061
Study: 8955968

Group type: EXPERIMENTAL
Intervention: Mixed group (mepivacaine 1% with 0.1 mg fentanyl)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mepivacaine group (1%)
Number of subjects: 30
Study: 1415021

Group type: EXPERIMENTAL
Intervention: 1 million units of recombinant interferon alpha‐2b
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 million units of recombinant interferon alpha‐2b, subcutaneously, three times a week for 24 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 80
Study: 4041321

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fentanyl plus nitrous oxide in oxygen (Control)
Number of subjects: 0
Study: 31201193

Group type: EXPERIMENTAL
Intervention: Adaptive deep brain stimulation (aDBS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional deep brain stimulation (cDBS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 12
Study: 29151409

Group type: COMPARATOR
Intervention: Continuous hemoperfusion (HP)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Paraquat detoxification recipe combined with HP
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Paraquat detoxification recipe combined with persistent HP
Number of subjects: 152
Study: 25555569

Group type: EXPERIMENTAL
Intervention: Eraser laser enucleation of the prostate (ELEP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic adenomectomy (LA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (LA and ELEP)
Number of subjects: 40
Study: 22692449

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Flank position
Number of subjects: 150
Study: 22374468

Group type: EXPERIMENTAL
Intervention: Nizatidine (150 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 19556077

Group type: EXPERIMENTAL
Intervention: Diabetic patients after carpal tunnel release
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nondiabetic patients after carpal tunnel release
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Diabetic patients grip strength
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nondiabetic patients grip strength
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Diabetic patients cold intolerance
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nondiabetic patients cold intolerance
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Patient satisfaction
Number of subjects: 35
Study: 16429411

Group type: EXPERIMENTAL
Intervention: Bilateral continuous intraputamenal infusion of liatermin 15 microg/putamen/day
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 14648125

Group type: EXPERIMENTAL
Intervention: Eccentric endurance training (EET)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Concentric endurance training (CET)
Number of subjects: 12
Study: 11292901

Group type: EXPERIMENTAL
Intervention: Surgical myocardial revascularization without cardiopulmonary bypass (group A)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Surgical myocardial revascularization with cardiopulmonary bypass (group B, control)
Number of subjects: 37
Study: 9130147

Group type: EXPERIMENTAL
Intervention: Self-selected neutral position
Number of subjects: 25

Group type: COMPARATOR
Intervention: 30 degrees of lower extremity turn-out from the self-selected neutral position
Number of subjects: 25
Study: 7955745

Group type: EXPERIMENTAL
Intervention: Upright radionuclide esophageal transit (RET) after pneumatic dilation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Supine radionuclide esophageal transit (RET) after successful dilation
Number of subjects: 4

Group type: COMPARATOR
Intervention: Supine and upright radionuclide esophageal transit (RET) before treatment
Number of subjects: 4

Group type: COMPARATOR
Intervention: Simple dilation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Pneumatic dilation
Number of subjects: 4
Study: 3296971

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGBP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vertical banded gastroplasty (VBGP)
Number of subjects: 40
Study: 31328871

Group type: EXPERIMENTAL
Intervention: Human umbilical cord blood-derived mesenchymal stem cell (hUCBMSC)-conditioned media containing cream with serum
Number of subjects: 23

Group type: COMPARATOR
Intervention: Human umbilical cord blood-derived mesenchymal stem cell (hUCBMSC)-conditioned media containing cream without serum
Number of subjects: 23
Study: 29482586

Group type: EXPERIMENTAL
Intervention: Culturally adapted internet-delivered cognitive behavioural therapy (iCBT) Space from Depression, consisting of 7 weekly modules with post-session feedback support.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list control group (no active treatment).
Number of subjects: 0
Study: 26658227

Group type: EXPERIMENTAL
Intervention: DPYD c.1129-5923 C>G and hapB3 variants
Number of subjects: 1953

Group type: EXPERIMENTAL
Intervention: Overall grade≥3 adverse events (AEs)
Number of subjects: 1953

Group type: EXPERIMENTAL
Intervention: Any grade≥3 5FU-AE
Number of subjects: 1953

Group type: EXPERIMENTAL
Intervention: DPYD c.1129-5923 C>G/hapB3
Number of subjects: 1953
Study: 24705119

Group type: EXPERIMENTAL
Intervention: Norwood procedure with right ventricle-to-pulmonary artery shunt (RVPAS)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Modified Blalock-Taussig shunt (MBTS)
Number of subjects: 549
Study: 23833846

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl with 0.1 mg morphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intrathecal fentanyl only
Number of subjects: 60
Study: 20666786

Group type: EXPERIMENTAL
Intervention: 8 mm, v4.1 mm Straumann Standard Plus tissue-level implants (Group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 10 mm, v4.1 mm Straumann Standard Plus tissue-level implants (Group B)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Lower bone density (Type III or IV)
Number of subjects: 32
Study: 18230239

Group type: EXPERIMENTAL
Intervention: Writing about a traumatic event
Number of subjects: 36

Group type: COMPARATOR
Intervention: Writing about time management
Number of subjects: 36
Study: 16698138

Group type: EXPERIMENTAL
Intervention: Telemedicine contact with a nutrition nurse specialist
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard contact with a nutrition nurse specialist by telephone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Opiate use
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acute onset of intestinal failure
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 30
Study: 14744403

Group type: EXPERIMENTAL
Intervention: Therapeutic options for hand dermatitis, including treatments for recalcitrant cases.
Number of subjects: 0
Study: 10839658

Group type: EXPERIMENTAL
Intervention: Fozivudine tidoxil (FZD) 200 mg daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fozivudine tidoxil (FZD) 400 mg daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fozivudine tidoxil (FZD) 200 mg twice daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fozivudine tidoxil (FZD) 800 mg daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fozivudine tidoxil (FZD) 400 mg twice daily
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Fozivudine tidoxil (FZD) 600 mg twice daily
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 8977752

Group type: EXPERIMENTAL
Intervention: Intravenous insulin 0.2 IU/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intravenous arginine 20 g/m2
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intramuscular glucagon 1 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral clonidine 100 micrograms
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oral clonidine 200 micrograms
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 1487621

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Lorazepam 1 mg (positive internal control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg with alcohol (0.6 g/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Lorazepam 1 mg with alcohol (0.6 g/kg)
Number of subjects: 15
Study: 6358069

Group type: COMPARATOR
Intervention: Conventional diet (CD) 1000 kcal (4.19 MJ)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Partial meal replacement (PMR) 1000 kcal (4.19 MJ)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pre-meal satiation (PMS) greater than or equal to 565 kcal (greater than or equal to 2.37 MJ)
Number of subjects: 120
Study: 31313123

Group type: EXPERIMENTAL
Intervention: Risk score model for sepsis associated-acute kidney injury (SA-AKI) developed using multivariate regression analysis
Number of subjects: 2617
Study: 29432461

Group type: EXPERIMENTAL
Intervention: Checkme device measurements by patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nurse measurements
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gold standard measurements
Number of subjects: 50
Study: 26942445

Group type: EXPERIMENTAL
Intervention: Intragastric glucose loads of 10 g, 25 g, and 75 g glucose dissolved in 300 ml tap water.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (normal weight subjects receiving the same glucose loads).
Number of subjects: 24
Study: 24481874

Group type: EXPERIMENTAL
Intervention: Evolocumab (subcutaneous, administered every 2 weeks or every month for 12 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ezetimibe
Number of subjects: 0
Study: 20104762

Group type: EXPERIMENTAL
Intervention: Wenxinkeli (5 g, 3 times a day with warm water) for 4 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (adenosine triphosphate, coenzyme A, vitamin C, coenzyme Q10 and other nutrients cardiac drugs) for 4 weeks
Number of subjects: 45
Study: 14977792

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion at 100 microg/min for 2 min, then titrated to maintain SBP at 100% of baseline.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion at 90% of baseline SBP.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion at 80% of baseline SBP.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion at 100% of baseline SBP.
Number of subjects: 74
Study: 11686426

Group type: EXPERIMENTAL
Intervention: Cefprozil, 500 mg twice daily for 5 days
Number of subjects: 295

Group type: COMPARATOR
Intervention: Clarithromycin, 500 mg twice daily for 10 days
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Cefprozil
Number of subjects: 295

Group type: COMPARATOR
Intervention: Clarithromycin
Number of subjects: 295
Study: 9784725

Group type: EXPERIMENTAL
Intervention: Enterosorbent polysorb and a complex of antioxidants (tocoferolum acetatum, ascorbic acid, quercetin) as a supplement to conventional therapy (Group I, n = 76)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Conventional therapy only (Group II, n = 67)
Number of subjects: 143
Study: 8163325

Group type: EXPERIMENTAL
Intervention: Exercise with rehydration
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Exercise without rehydration
Number of subjects: 4

Group type: COMPARATOR
Intervention: Baseline (Sedentary)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Exercise in cool season
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Exercise in hot season
Number of subjects: 4
Study: 3280363

Group type: EXPERIMENTAL
Intervention: Domiodol (0.5 mg/kg three times daily for 14 days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Domiodol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11397997

Group type: COMPARATOR
Intervention: β-sympathomimetics
Number of subjects: 708

Group type: COMPARATOR
Intervention: Oral maintenance treatment with ritodrine
Number of subjects: 708

Group type: COMPARATOR
Intervention: Subcutaneous administration of β-sympathomimetics
Number of subjects: 708

Group type: EXPERIMENTAL
Intervention: Prolonged treatment by β-sympathomimetics
Number of subjects: 708
Study: 31335171

Group type: EXPERIMENTAL
Intervention: Pizza B (long dough fermentation)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Pizza A (short dough fermentation)
Number of subjects: 38
Study: 29975298

Group type: EXPERIMENTAL
Intervention: Raw EMG signals and EMG intensities
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: EMG intensities of individual muscles (excluding quadriceps)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Coordination patterns
Number of subjects: 9
Study: 26980230

Group type: EXPERIMENTAL
Intervention: Intramuscular oxytocin
Number of subjects: 256

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 256
Study: 25059851

Group type: EXPERIMENTAL
Intervention: Advanced cryotherapy
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cold packs
Number of subjects: 116
Study: 22607850

Group type: EXPERIMENTAL
Intervention: aCRT (adaptive cardiac resynchronization therapy)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Echo (echo-optimized biventricular pacing)
Number of subjects: 522
Study: 20434074

Group type: EXPERIMENTAL
Intervention: Snack Smart workshops
Number of subjects: 49
Study: 17509304

Group type: EXPERIMENTAL
Intervention: Premarin 1.25 mg 3 times daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Premarin 1.25 mg once daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Premarin 1.25 mg 3 times daily and warfarin 1 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Premarin 1.25 mg once daily and warfarin 1 mg
Number of subjects: 45
Study: 16027622

Group type: EXPERIMENTAL
Intervention: Fränkel appliance therapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Untreated Class II malocclusions
Number of subjects: 78

Group type: COMPARATOR
Intervention: Normal occlusions
Number of subjects: 78
Study: 12458696

Group type: EXPERIMENTAL
Intervention: Massage therapy, 20-minute sessions, twice a week for five weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Relaxation therapy, 20-minute sessions, twice a week for five weeks
Number of subjects: 17
Study: 10515238

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 12
Study: 7587018

Group type: EXPERIMENTAL
Intervention: Relevance Theory based explanation of the Wason Selection Task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rule-context pairs devised for the Selection Task
Number of subjects: 0
Study: 1902997

Group type: EXPERIMENTAL
Intervention: Hemofil M
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Monoclate HT
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Monoclate P
Number of subjects: 10
Study: 7019785

Group type: EXPERIMENTAL
Intervention: Sodium selenite or selenomethionine (100 micrograms Se daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31097213

Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanic acid
Number of subjects: 3427

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 3427
Study: 28832924

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 25670919

Group type: EXPERIMENTAL
Intervention: Pre-warmed group (warmed 30 minutes before induction with a forced-air warming blanket set at 38°C)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (not pre-warmed)
Number of subjects: 72
Study: 24307184

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Usual care (diabetes support and education [DSE])
Number of subjects: 5145
Study: 21895543

Group type: EXPERIMENTAL
Intervention: R-miniCEOP
Number of subjects: 224

Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 224
Study: 19675867

Group type: EXPERIMENTAL
Intervention: Gamma probe completion thyroidectomy (GPCT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional completion thyroidectomy
Number of subjects: 100
Study: 17473143

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis plus intermittent pneumatic compression
Number of subjects: 1803

Group type: COMPARATOR
Intervention: Chemoprophylaxis alone
Number of subjects: 1803

Group type: EXPERIMENTAL
Intervention: Chemoprophylaxis plus intermittent pneumatic compression (more than six hours daily)
Number of subjects: 1803
Study: 15148925

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg daily (qd) for 6 weeks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice a day (bid) for 6 weeks
Number of subjects: 64
Study: 11939160

Group type: EXPERIMENTAL
Intervention: Ganirelix
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gonadotrophin-releasing hormone agonists (buserelin, leuprolide, triptorelin)
Number of subjects: 0
Study: 9690949

Group type: EXPERIMENTAL
Intervention: Itraconazole 100 mg orally once daily for 4 days
Number of subjects: 10
Study: 7866002

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (points ST36, LI11, RN6, and symptomatic points bilaterally) for 30 minutes daily for 10 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 45
Study: 2562387

Group type: EXPERIMENTAL
Intervention: Guar gum (15 g/day, divided in three doses with major meals)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 35
Study: 1145134

Group type: EXPERIMENTAL
Intervention: Cloxacillin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dicloxacillin
Number of subjects: 12
Study: 30184309

Group type: EXPERIMENTAL
Intervention: Multisensory cues
Number of subjects: 181

Group type: COMPARATOR
Intervention: Unisensory cues
Number of subjects: 181
Study: 29158435

Group type: EXPERIMENTAL
Intervention: High diary use
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Very high diary use
Number of subjects: 393

Group type: COMPARATOR
Intervention: No diary use
Number of subjects: 393
Study: 25543065

Group type: EXPERIMENTAL
Intervention: Alcohol consumption after stress in FHP-HCR (high cortisol responders)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo intake
Number of subjects: 58
Study: 23528148

Group type: EXPERIMENTAL
Intervention: Self-management psychosocial intervention
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 48
Study: 21993043

Group type: EXPERIMENTAL
Intervention: 1-minute rest interval (RI) during horizontal leg press (LP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3-minute rest interval (RI) during horizontal leg press (LP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-minute rest interval (RI) during chest fly (CF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3-minute rest interval (RI) during chest fly (CF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1-minute and 3-minute rest intervals (RI) during horizontal leg press (LP) and chest fly (CF)
Number of subjects: 10